Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
Erik Kúdela, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7691-7691
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 9
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
Predictive biomarkers for personalized medicine in breast cancer
Sylvie Rodrigues-Ferreira, Clara Nahmias
Cancer Letters (2022) Vol. 545, pp. 215828-215828
Open Access | Times Cited: 34
The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response
Andrea Favero, Ilenia Segatto, Tiziana Perin, et al.
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 37
Assessment of the Efficacy and Pulmonary Toxicity of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer in a Tertiary Center in the United Arab Emirates
Mohammad Hourani, Rawan Bdair, Emad Dawoud, et al.
Cureus (2025)
Open Access
miRNAs as emerging predictors of tamoxifen resistance in breast cancer
Elmira Aboutalebi Vand Beilankouhi, Reza Safaralizadeh, Babak Nejati, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
From Breast to Eye: A Rare Case of Ocular Metastasis From Luminal Breast Cancer in a Nicaraguan Patient
Gilberto A Altamirano, Christopher Romero, Catherine S Moreno Cabrera, et al.
Cureus (2025)
Open Access
The Role of miR-155 in Nutrition: Modulating Cancer-Associated Inflammation
Oana Zănoagă, Cornelia Braicu, Paul Chiroi, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2245-2245
Open Access | Times Cited: 24
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
Alfiah Amiruddin, Muhammad Nasrum Massi, Andi Asadul Islam, et al.
Annals of Medicine and Surgery (2021) Vol. 73
Open Access | Times Cited: 23
MicroRNAs as a clue to overcome breast cancer treatment resistance
Iris Garrido‐Cano, B. Pattanayak, Anna Adam‐Artigues, et al.
Cancer and Metastasis Reviews (2021) Vol. 41, Iss. 1, pp. 77-105
Open Access | Times Cited: 21
Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer
Thomas Helland, Sarah Alsomairy, Chenchia Lin, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 201-201
Open Access | Times Cited: 20
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective
Valentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5326-5326
Open Access | Times Cited: 14
Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
Mona A. Abbas, Ibrahim El Tantawy El Sayed, Azza Mohamed Kamel Abdu-Allah, et al.
Non-coding RNA Research (2022) Vol. 7, Iss. 4, pp. 248-257
Open Access | Times Cited: 12
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 6, pp. 265-277
Closed Access | Times Cited: 2
Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma
Anning Zuo, Jinyu Li, Siyuan Weng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 5, pp. 1821-1833
Closed Access | Times Cited: 2
Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa
Savera Shahzad, Najeeb Ullah Khan, Wafa Sombal, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 3, pp. 2445-2451
Open Access | Times Cited: 6
MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome
Yu Men, Yirui Zhai, Lihong Wu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Circulating miRNA Expression Profiling in Breast Cancer Molecular Subtypes: Applying Machine Learning Analysis in Bioinformatics
Alexandra Triantafyllou, Nikolas Dovrolis, Eleni Zografos, et al.
Cancer Diagnosis & Prognosis (2022) Vol. 2, Iss. 6, pp. 739-749
Open Access | Times Cited: 8
Clinical significance of the CXCL8/CXCR1/R2 signalling axis in patients with invasive breast cancer
Sebastian Stępień, Marta Smycz‐Kubańska, Celina Kruszniewska‐Rajs, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 1
Evaluation of Tumorigenic Properties of MDA-MB-231 Cancer Stem Cells Cocultured with Telocytes and Telocyte-Derived Mitochondria Following miR-146a Inhibition
Sena Babadag, Özlem Altundag, Yeliz Z. Akkaya‐Ulum, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 7, pp. 341-352
Closed Access | Times Cited: 1
Role of RUNX2 in breast cancer development and drug resistance (Review)
Wentao Si, Kan Chen, Leisheng Zhang, et al.
Oncology Letters (2023) Vol. 25, Iss. 5
Open Access | Times Cited: 4
Synthesis and Regulation of miRNA, Its Role in Oncogenesis, and Its Association with Colorectal Cancer Progression, Diagnosis, and Prognosis
Monika Rać
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1450-1450
Open Access | Times Cited: 1
Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma
Tirta Wardana, Siti Nur Chasanah, Risky Oktriani, et al.
Non-coding RNA Research (2022) Vol. 7, Iss. 4, pp. 233-241
Open Access | Times Cited: 4
Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning
Qinglan Ma, Lei Chen, Kai‐Yan Feng, et al.
Biochemical Genetics (2024) Vol. 62, Iss. 6, pp. 5022-5050
Closed Access
Identifying miRNA as biomarker for breast cancer subtyping using association rule
Fatimah Audah Md. Zaki, Ezanee Azlina Mohamad Hanif
Computers in Biology and Medicine (2024) Vol. 178, pp. 108696-108696
Closed Access
Page 1 - Next Page

Scroll to top